These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20847212)

  • 1. Significantly higher frequencies of alloreactive CD4+ T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities.
    Sizzano F; Zito L; Crivello P; Crocchiolo R; Vago L; Zino E; Fleischhauer K
    Blood; 2010 Sep; 116(11):1991-2. PubMed ID: 20847212
    [No Abstract]   [Full Text] [Related]  

  • 2. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.
    Zino E; Frumento G; Marktel S; Sormani MP; Ficara F; Di Terlizzi S; Parodi AM; Sergeant R; Martinetti M; Bontadini A; Bonifazi F; Lisini D; Mazzi B; Rossini S; Servida P; Ciceri F; Bonini C; Lanino E; Bandini G; Locatelli F; Apperley J; Bacigalupo A; Ferrara GB; Bordignon C; Fleischhauer K
    Blood; 2004 Feb; 103(4):1417-24. PubMed ID: 14576061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permissive, nonpermissive HLA-DPB1 epitope disparities and the specificity of T cells infiltrating the skin during acute graft-versus-host disease.
    Vié H; Gaschet J; Milpied N
    Blood; 2011 May; 117(21):5779-81. PubMed ID: 21617014
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of an immunodominant region of Fel d 1 and characterization of constituent epitopes.
    Bateman EA; Ardern-Jones MR; Ogg GS
    Clin Exp Allergy; 2008 Nov; 38(11):1760-8. PubMed ID: 19489916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation.
    Crivello P; Zito L; Sizzano F; Zino E; Maiers M; Mulder A; Toffalori C; Naldini L; Ciceri F; Vago L; Fleischhauer K
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):233-41. PubMed ID: 25445022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro.
    Rutten CE; van Luxemburg-Heijs SA; van der Meijden ED; Griffioen M; Oudshoorn M; Willemze R; Falkenburg JH
    Blood; 2010 Jan; 115(1):151-3. PubMed ID: 20056799
    [No Abstract]   [Full Text] [Related]  

  • 7. Of cats and men: immunodominance and the role of HLA-DP/DQ.
    Larché M
    Clin Exp Allergy; 2008 Nov; 38(11):1709-11. PubMed ID: 19489915
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation.
    Zino E; Vago L; Di Terlizzi S; Mazzi B; Zito L; Sironi E; Rossini S; Bonini C; Ciceri F; Roncarolo MG; Bordignon C; Fleischhauer K
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1031-40. PubMed ID: 17697965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing.
    Arrieta-Bolaños E; Crivello P; Metzing M; Meurer T; Ahci M; Rytlewski J; Vignali M; Yusko E; van Balen P; Horn PA; Falkenburg JHF; Fleischhauer K
    Front Immunol; 2018; 9():280. PubMed ID: 29520276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
    Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
    J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1-specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles.
    Rutten CE; van Luxemburg-Heijs SA; van der Meijden ED; Griffioen M; Oudshoorn M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1282-92. PubMed ID: 20350610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.
    Grifoni A; Moore E; Voic H; Sidney J; Phillips E; Jadi R; Mallal S; De Silva AD; De Silva AM; Peters B; Weiskopf D; Sette A
    Front Immunol; 2019; 10():1568. PubMed ID: 31333679
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G protein.
    de Waal L; Yüksel S; Brandenburg AH; Langedijk JP; Sintnicolaas K; Verjans GM; Osterhaus AD; de Swart RL
    J Virol; 2004 Feb; 78(4):1775-81. PubMed ID: 14747542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scanning the HIV genome for CD4+ T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule.
    Cohen WM; Pouvelle-Moratille S; Wang XF; Farci S; Munier G; Charron D; Ménez A; Busson M; Maillère B
    J Immunol; 2006 May; 176(9):5401-8. PubMed ID: 16622007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells.
    Yang J; Huston L; Berger D; Danke NA; Liu AW; Disis ML; Kwok WW
    J Clin Immunol; 2005 Sep; 25(5):428-36. PubMed ID: 16160911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.
    Rutten CE; van Luxemburg-Heijs SA; Griffioen M; Marijt EW; Jedema I; Heemskerk MH; Posthuma EF; Willemze R; Falkenburg JH
    Leukemia; 2008 Jul; 22(7):1387-94. PubMed ID: 18418406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.
    Voo KS; Fu T; Heslop HE; Brenner MK; Rooney CM; Wang RF
    Cancer Res; 2002 Dec; 62(24):7195-9. PubMed ID: 12499257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer.
    Chikamatsu K; Sakakura K; Takahashi G; Okamoto A; Furuya N; Whiteside TL; DeLeo AB; Masuyama K
    Cancer Immunol Immunother; 2009 Sep; 58(9):1441-8. PubMed ID: 19184003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.
    Fleischhauer K; Shaw BE; Gooley T; Malkki M; Bardy P; Bignon JD; Dubois V; Horowitz MM; Madrigal JA; Morishima Y; Oudshoorn M; Ringden O; Spellman S; Velardi A; Zino E; Petersdorf EW;
    Lancet Oncol; 2012 Apr; 13(4):366-74. PubMed ID: 22340965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM.
    Meurer T; Crivello P; Metzing M; Kester M; Megger DA; Chen W; van Veelen PA; van Balen P; Westendorf AM; Homa G; Layer SE; Turki AT; Griffioen M; Horn PA; Sitek B; Beelen DW; Falkenburg JHF; Arrieta-Bolaños E; Fleischhauer K
    Blood; 2021 Feb; 137(7):923-928. PubMed ID: 33025005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.